MicroRNAs as diagnostic and prognostic biomarkers in colorectal cancer

N/ACitations
Citations of this article
55Readers
Mendeley users who have this article in their library.

Abstract

MicroRNAs (miRNAs) are key regulators involved in various tumors. They regulate cell cycle, apoptosis and cancer stemness, metastasis and chemoresistance by controlling their target gene expressions. Here, we mainly discuss the potential uses of miRNAs in colorectal cancer (CRC) diagnosis. We also shed light on the important corresponding miRNA targets and on the major regulators of miRNAs. Furthermore, we discuss miRNA activity in assessing the prognosis and recurrence of CRC as well as in modulating responsiveness to chemotherapy. Based on the various pro-oncogenic/anti-oncogenic roles of miRNAs, the advantages of a therapeutic strategy based on the delivery of miRNA mimics are also mentioned. Together, miRNA seems to be an excellent tool for effectively monitoring and targeting CRC.

Cite

CITATION STYLE

APA

Yi, R., Li, Y., Wang, F. L., Miao, G., Qi, R. M., & Zhao, Y. Y. (2016). MicroRNAs as diagnostic and prognostic biomarkers in colorectal cancer. World Journal of Gastrointestinal Oncology, 8(4), 330–340. https://doi.org/10.4251/wjgo.v8.i4.330

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free